The American Journal of Surgery
Volume 197, Issue 5 , Pages 643-647 , May 2009

Intraoperative evaluation of sentinel lymph nodes in invasive lobular carcinoma of the breast

  • Angie R. Taras, M.D.

      Affiliations

    • Swedish Cancer Institute, Swedish Medical Center, Seattle, WA, USA
    • ,
  • Nyle A. Hendrickson, M.D.

      Affiliations

    • Swedish Cancer Institute, Swedish Medical Center, Seattle, WA, USA
    • ,
  • Matthew S. Pugliese, M.D.

      Affiliations

    • Swedish Cancer Institute, Swedish Medical Center, Seattle, WA, USA
    • ,
  • Kimberly A. Lowe, Ph.D.

      Affiliations

    • Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    • ,
  • Mary Atwood, CTR

      Affiliations

    • Swedish Cancer Institute, Swedish Medical Center, Seattle, WA, USA
    • ,
  • J. David Beatty, M.D.

      Affiliations

    • Swedish Cancer Institute, Swedish Medical Center, Seattle, WA, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-206-215-6400; fax: +1-206-215-6401

Received 8 November 2008 ,Revised 23 December 2008

References 

  1. Mclaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol. 2008;26:5213–5219
  2. Wilke LG, McCall LM, Posther KE, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol. 2006;12:491–500
  3. Li C, Anderson BO, Porter P, et al. Changing incidence rate of invasive lobular breast carcinoma among older women. Cancer. 2000;88:2561–2569
  4. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391–398
  5. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA. 1996;276:1818–1822
  6. Kelley MC, Hansen N, McMasters KM. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Am J Surg. 2004;188:49–61
  7. Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP-32 randomised phase III trial. Lancet Oncol. 2007;8:881–888
  8. Heuts EM, van der Ent FWC, Hulsewe KWE, et al. Incidence of axillary recurrence in 344 sentinel node negative breast cancer patients after intermediate follow-up (A prospective study into the accuracy of sentinel node biopsy in breast cancer patients). Acta Chir Belg. 2007;107:279–283
  9. Chan SW, LaVigne KA, Port ER, et al. Does the benefit of sentinel node frozen section vary between patients with invasive duct, invasive lobular, and favorable histologic subtypes of breast cancer?. Ann Surg. 2008;247:143–149
  10. Pugliese MS, Tickman R, Wang NP, et al. The utility of intraoperative evaluation of sentinel lymph nodes in breast cancer. Ann Surg Oncol. 2007;14:1024–1030
  11. Pugliese MS, Kohr JR, Allison KH, et al. Accuracy of intraoperative imprint cytology of sentinel lymph nodes in breast cancer. Am J Surg. 2006;192:516–519
  12. Lyman GH, Giuliano AE, Somerfeld MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703–7720
  13. NCCN Practice Guidelines in Oncology-v.2.2006 (Breast Cancer). http://www.nccn.org/professionals/physician_gls/PDF/breast.pdfAccessed: October 31, 2008
  14. Goyal A, Newcombe RG, Chhabra A, et al. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer-results of the ALMANAC validation phase. Breast Cancer Res Treat. 2006;99:203–208
  15. Goyal A, Newcombe RG, Chhabra A, et al. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND. Ann Surg Oncol. 2007;15:262–267
  16. Pugliese MS, Beatty JD, Tickman RJ, et al. Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories. Ann Surg Oncol. 2009;16:113–120

 Financial support for this study was partially provided by the Safeway Fund, Swedish Foundation as well as a grant from the Department of Defense/CDMRP, DAMD17-02-0691.

PII: S0002-9610(09)00078-6

doi: 10.1016/j.amjsurg.2008.12.019

The American Journal of Surgery
Volume 197, Issue 5 , Pages 643-647 , May 2009

Article Tools